SPEEDUS CORP. Inactive Instrument
Speedus Corp. Share Price Other OTC
Equities
SPDE
US8477232024
Advanced Medical Equipment & Technology
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2008 | 156K 12.97M | Sales 2009 | 461K 38.37M | Capitalization | 10.39M 865M |
|---|---|---|---|---|---|
| Net income 2008 | -9M -749M | Net income 2009 | -2M -166M | EV / Sales 2008 | -21.8 x |
| Net cash position 2008 | 4.93M 410M | Net cash position 2009 | 548K 45.63M | EV / Sales 2009 | 21.3 x |
| P/E ratio 2008 |
-0.17
x | P/E ratio 2009 |
-3.66
x | Employees | - |
| Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 35.15% |
More Fundamentals
* Assessed data
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/95/01 | |
Thomas A. Finn
DFI | Director of Finance/CFO | 73 | 01/03/01 |
Patrick Hodge
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/95/01 |
Speedus Corp. (Speedus) operates primarily through its two majority-owned subsidiaries, Zargis Medical Corp. (Zargis) and Density Dynamics Corp. (DDC). Zargis is a medical device company focused on the development of computer-aided medical devices and telemedicine-based delivery systems. DDC is engaged in the development of its line of dynamic random access memory (DRAM)-based, solid-state storage and input/output (I/O) acceleration technology. As of December 31, 2009, the Company held approximately 90% ownership interest in Zargis.
| 1st Jan change | Capi. | |
|---|---|---|
| +11.18% | 225B | |
| +15.22% | 197B | |
| +19.19% | 143B | |
| +30.89% | 111B | |
| +1.56% | 64.72B | |
| +18.48% | 54.44B | |
| +5.12% | 51.06B | |
| +10.53% | 45.03B | |
| +5.98% | 37.4B |
